LAVEENA SULLHAN: Open Payments
NPI 1316548431 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 38 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $319 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $225 |
| Amgen Inc. | 10 | $155 |
| Exact Sciences Corporation | 6 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| PFIZER INC. | 2 | $57 |
| Lilly USA, LLC | 2 | $42 |
| Intra-Sana Laboratories | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: Wegovy, OTEZLA, Cologuard Collection Kit, Ozempic, Kerendia, NURTEC ODT, MOUNJARO, RELTONE 200 MG.
Industry payments across NV — which companies pay providers there.
